University of Illinois Urbana-Champaign

Improving cancer therapy strategies via cellular stress and immune modulation

Lee, Yoongyeong

This item's files can only be accessed by the System Administrators group.

Permalink

https://hdl.handle.net/2142/132761

Description

Title
Improving cancer therapy strategies via cellular stress and immune modulation
Author(s)
Lee, Yoongyeong
Issue Date
2025-11-25
Director of Research (if dissertation) or Advisor (if thesis)
Fan, Timothy M
Doctoral Committee Chair(s)
Fan, Timothy M
Committee Member(s)
  • Hergenrother, Paul J
  • Spinella, Michael J
  • Ko, CheMyong
  • Wang, Bo
Department of Study
Comparative Biosciences
Discipline
VMS - Comparative Biosciences
Degree Granting Institution
University of Illinois Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
  • Bone cancer
  • Lung cancer
  • ErSO
  • TRPM4
  • UPR
  • CBD
  • anti-PD-1
Abstract
Despite significant progress in molecularly targeted and immune-based therapies, metastatic and chemoresistant cancers continue to exhibit poor clinical outcomes. This dissertation investigates two distinct therapeutic strategies designed to overcome tumor resistance and improve therapeutic efficacy. The first component of this work focuses on the small molecule ErSO, which induces cell death through hyperactivation of the unfolded protein response (UPR). Preclinical studies in osteosarcoma (OS), chondrosarcoma (CS), and Ewing sarcoma (ES) demonstrated potent ErSO mediated cytotoxicity and anti-metastatic activity, significantly extending survival even in late stage, chemoresistant models. Mechanistic analyses revealed that ErSO activity is independent of estrogen receptor alpha (ERα) but critically dependent on plasma membrane-localized TRPM4 which induces ATF6-mediate cell death. Immunohistochemical analysis of human OS tissues confirmed that TRPM4 is widely expressed, suggesting that a substantial subset of bone cancer patients may be responsive to ErSO-based therapy. The second component examines cannabidiol (CBD) as an immune microenvironment modulator and its interaction with anti-PD-1 checkpoint therapy in lung cancer. Although CBD broadly impairs functional immune activity under stimulatory conditions, its combination with anti-PD-1 antibody significantly reduced tumor burden in vivo compared with either monotherapy. Transcriptomic analysis revealed that CBD selectively decreased regulatory T cell (Treg) activity, improving the CD8+/Treg balance and enhancing antitumor immunity. These findings suggest that under certain conditions, CBD can refine rather than impair immune checkpoint therapy by selectively mitigating pro-tumor immune suppression. Collectively, this dissertation establishes two distinct therapeutic avenues: 1) TRPM4-mediate ErSO cytotoxicity for treating advanced bone cancers, and 2) CBD-driven immune modulation to potentiate checkpoint blockade in lung cancer.
Graduation Semester
2025-12
Type of Resource
Thesis
Handle URL
https://hdl.handle.net/2142/132761
Copyright and License Information
Copyright 2025 Yoongyeong Lee

Owning Collections

Graduate Dissertations and Theses at Illinois PRIMARY
Graduate Theses and Dissertations at Illinois